410 related articles for article (PubMed ID: 25850749)
21. Combination therapies for hypertension - why we need to look beyond RAS blockers.
Gorostidi M; de la Sierra A
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):841-853. PubMed ID: 30092149
[TBL] [Abstract][Full Text] [Related]
22. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP).
McInnis NH; Fodor G; Moy Lum-Kwong M; Leenen FH
Am J Hypertens; 2008 Nov; 21(11):1210-5. PubMed ID: 18772857
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
Chen JM; Heran BS; Perez MI; Wright JM
Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
[TBL] [Abstract][Full Text] [Related]
26. ACE-inhibitor/calcium antagonist combination: is this the first-choice therapy in arterial hypertension?
Taddei S
Minerva Med; 2019 Dec; 110(6):546-554. PubMed ID: 31965780
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
28. The rationale for combination versus single-entity therapy in hypertension.
Weir MR
Am J Hypertens; 1998 Oct; 11(10):163S-169S. PubMed ID: 9799051
[TBL] [Abstract][Full Text] [Related]
29. Hypertension control in the elderly.
Neutel JM; Gilderman LI
J Clin Hypertens (Greenwich); 2008 Jan; 10(1 Suppl 1):33-9. PubMed ID: 18174782
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy as first-line treatment for hypertension.
Crawford MH
Am J Cardiovasc Drugs; 2009; 9(1):1-6. PubMed ID: 19178127
[TBL] [Abstract][Full Text] [Related]
31. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
Neutel JM
Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
[TBL] [Abstract][Full Text] [Related]
32. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
33. Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.
Deedwania P
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):883-8. PubMed ID: 17978596
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
Waeber B
Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
[TBL] [Abstract][Full Text] [Related]
35. Management of hypertension with fixed-dose triple-combination treatments.
Epstein BJ; Shah NK; Borja-Hart NL
Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
[TBL] [Abstract][Full Text] [Related]
36. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
37. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.
Heran BS; Chen JM; Wang JJ; Wright JM
Cochrane Database Syst Rev; 2010 Jan; (1):CD008167. PubMed ID: 20091662
[TBL] [Abstract][Full Text] [Related]
39. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
[TBL] [Abstract][Full Text] [Related]
40. A new dimension in hypertension management with the amlodipine/perindopril combination.
Poulter NR
J Hypertens; 2011 Dec; 29 Suppl 1():S15-21. PubMed ID: 22157563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
